Canadian Digestive Diseases Week (CDDW) 2018
BUHLMANN Diagnostics Corp
Booth: #135
Feb 09 – 11, 2018 | The Fairmont Royal York | Toronto, ON
Come by our booth to get an update on our Calprotectin and Therapeutic Drug Monitoring product portfolio:
IBDoc®, the ONLY in-vitro diagnostic POC and home testing device to measure the inflammatory marker, fecal calprotectin
Health Canada License: 98903, Device class: 3
US: Not available for Sale in the US.
Quantum Blue® platform offering rapid and quantitative results for fecal calprotectin, serum calprotectin, CRP and serum infliximab trough levels (Additional trough level assays coming soon!)
Health Canada Licenses: Quantum Blue® fCAL: 83477, Quantum Blue® fCAL extended: 100161
US: Research Use Only. Not for use in diagnostic procedures in the US
BÜHLMANN fCAL® ELISA, the most referenced assay for fecal calprotectin
Health Canada License: 80726
US: Research Use Only. Not for use in diagnostic procedures in the US
BÜHLMANN fCAL® turbo, the new high throughput, random access fecal calprotectin assay. Available for virtually all Clinical Chemistry Analyzers allowing time to result of 10 minutes
Health Canada License: 96808
US: Research Use Only. Not for use in diagnostic procedures in the US
CALEX® Cap for rapid, clean, consistent and safe stool extraction
Health Canada License: 98839
US: Research Use Only. Not for use in diagnostic procedures in the US
Collin Shaw, VP of Business Development
Jennifer Stuart, Technical Sales Specialist
COLLIN SHAW
VP of Business Development
JENNIFER STUART
Technical Sales Specialist
